Logo image of EXRO.CA

EXRO TECHNOLOGIES INC (EXRO.CA) Stock Fundamental Analysis

TSX:EXRO - Toronto Stock Exchange - CA30222R1091 - Common Stock - Currency: CAD

0.13  +0 (+1.96%)

Fundamental Rating

1

Taking everything into account, EXRO scores 1 out of 10 in our fundamental rating. EXRO was compared to 14 industry peers in the Electrical Equipment industry. EXRO has a bad profitability rating. Also its financial health evaluation is rather negative. EXRO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

EXRO had negative earnings in the past year.
EXRO had a negative operating cash flow in the past year.
In the past 5 years EXRO always reported negative net income.
EXRO had a negative operating cash flow in each of the past 5 years.
EXRO.CA Yearly Net Income VS EBIT VS OCF VS FCFEXRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

Looking at the Return On Assets, with a value of -163.85%, EXRO is doing worse than 64.29% of the companies in the same industry.
EXRO's Return On Equity of -1272.39% is on the low side compared to the rest of the industry. EXRO is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
ROA -163.85%
ROE -1272.39%
ROIC N/A
ROA(3y)-104.76%
ROA(5y)-77.92%
ROE(3y)-507.54%
ROE(5y)-322.11%
ROIC(3y)N/A
ROIC(5y)N/A
EXRO.CA Yearly ROA, ROE, ROICEXRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

EXRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXRO.CA Yearly Profit, Operating, Gross MarginsEXRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

0

2. Health

2.1 Basic Checks

EXRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
EXRO has more shares outstanding than it did 1 year ago.
EXRO has more shares outstanding than it did 5 years ago.
EXRO has a worse debt/assets ratio than last year.
EXRO.CA Yearly Shares OutstandingEXRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
EXRO.CA Yearly Total Debt VS Total AssetsEXRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

EXRO has an Altman-Z score of -4.87. This is a bad value and indicates that EXRO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EXRO (-4.87) is worse than 64.29% of its industry peers.
EXRO has a Debt/Equity ratio of 4.77. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of EXRO (4.77) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.77
Debt/FCF N/A
Altman-Z -4.87
ROIC/WACCN/A
WACC5.72%
EXRO.CA Yearly LT Debt VS Equity VS FCFEXRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

EXRO has a Current Ratio of 0.85. This is a bad value and indicates that EXRO is not financially healthy enough and could expect problems in meeting its short term obligations.
EXRO has a Current ratio of 0.85. This is in the lower half of the industry: EXRO underperforms 71.43% of its industry peers.
A Quick Ratio of 0.17 indicates that EXRO may have some problems paying its short term obligations.
EXRO's Quick ratio of 0.17 is on the low side compared to the rest of the industry. EXRO is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.17
EXRO.CA Yearly Current Assets VS Current LiabilitesEXRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

The earnings per share for EXRO have decreased strongly by -103.33% in the last year.
The Revenue has grown by 303.01% in the past year. This is a very strong growth!
EPS 1Y (TTM)-103.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
Revenue 1Y (TTM)303.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%620.96%

3.2 Future

The Earnings Per Share is expected to grow by 37.52% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXRO will show a very strong growth in Revenue. The Revenue will grow by 114.52% on average per year.
EPS Next Y82.72%
EPS Next 2Y37.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year75.24%
Revenue Next 2Y125.91%
Revenue Next 3Y114.52%
Revenue Next 5YN/A

3.3 Evolution

EXRO.CA Yearly Revenue VS EstimatesEXRO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
EXRO.CA Yearly EPS VS EstimatesEXRO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

EXRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXRO.CA Price Earnings VS Forward Price EarningsEXRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EXRO.CA Per share dataEXRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as EXRO's earnings are expected to grow with 37.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.52%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EXRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXRO TECHNOLOGIES INC

TSX:EXRO (5/7/2025, 7:00:00 PM)

0.13

+0 (+1.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners17.14%
Inst Owner ChangeN/A
Ins Owners12.93%
Ins Owner ChangeN/A
Market Cap71.44M
Analysts45.45
Price Target0.15 (15.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-411.86%
Min EPS beat(2)-796.95%
Max EPS beat(2)-26.76%
EPS beat(4)2
Avg EPS beat(4)-203.78%
Min EPS beat(4)-796.95%
Max EPS beat(4)6.63%
EPS beat(8)4
Avg EPS beat(8)-110.84%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-37.4%
Min Revenue beat(2)-37.76%
Max Revenue beat(2)-37.05%
Revenue beat(4)0
Avg Revenue beat(4)-46.58%
Min Revenue beat(4)-69.33%
Max Revenue beat(4)-37.05%
Revenue beat(8)1
Avg Revenue beat(8)-39.42%
Revenue beat(12)4
Avg Revenue beat(12)139.5%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-69.02%
PT rev (3m)-69.02%
EPS NQ rev (1m)12.5%
EPS NQ rev (3m)12.5%
EPS NY rev (1m)0.88%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)-49.39%
Revenue NQ rev (3m)-41.58%
Revenue NY rev (1m)-50.82%
Revenue NY rev (3m)-49.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 3.15
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.04
BVpS0.04
TBVpS-0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -163.85%
ROE -1272.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-104.76%
ROA(5y)-77.92%
ROE(3y)-507.54%
ROE(5y)-322.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 4.77
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.51%
Cap/Sales 8.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.17
Altman-Z -4.87
F-Score2
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)244.82%
Cap/Depr(5y)539.1%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.55%
EPS Next Y82.72%
EPS Next 2Y37.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)303.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%620.96%
Revenue Next Year75.24%
Revenue Next 2Y125.91%
Revenue Next 3Y114.52%
Revenue Next 5YN/A
EBIT growth 1Y-112.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.79%
EBIT Next 3Y26.22%
EBIT Next 5YN/A
FCF growth 1Y-3.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.79%
OCF growth 3YN/A
OCF growth 5YN/A